Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2019741 | 0.77 | TRPA1 (0.33) | MIFTRPA1NAAA | |
| SCHEMBL114874 | 0.74 | — | — | |
| SCHEMBL19182915 | 0.72 | — | — | |
| SCHEMBL550615 | 0.72 | NAAA (0.45) | MIFTRPA1NAAAALDH1A1 | |
| SCHEMBL2772741 | 0.71 | TRPA1 (0.39) | MIFTRPA1NAAAALDH1A1 | |
| SCHEMBL3835195 | 0.70 | NAAA (0.48) | MIFTRPA1NAAAALDH1A1 | |
| SCHEMBL17868114 | 0.69 | — | — | |
| SCHEMBL28819833 | 0.68 | NAAA (0.32) | NAAA | |
| SCHEMBL4905526 | 0.67 | — | — | |
| SCHEMBL450056 | 0.61 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103524714-B | As the silane compound/carbamide compound of the heat-activatable solidifying agent for composition epoxy resin | SIKA TECHNOLOGY AG (CH) | 2016-04-06 | — | — | CN | disclosed |
| US-8728271-B2 | Silane/urea compound as a heat-activatable curing agent for epoxide resin compositions | SIKA TECHNOLOGY AG (CH) | 2014-05-20 | — | — | US | disclosed |
| CN-102131817-B | Silane/urea compounds as heat-activatable curing agents for epoxy resin compositions | SIKA TECHNOLOGY AG | 2014-05-07 | — | — | CN | disclosed |
| CN-103524714-A | Silane/urea compound as heat-activatable curing agent for epoxide resin compositions | SIKA TECHNOLOGY AG | 2014-01-22 | — | — | CN | disclosed |
| CN-102131817-A | Silane/urea compounds as heat-activatable curing agents for epoxy resin compositions | SIKA TECHNOLOGY AG | 2011-07-20 | — | — | CN | disclosed |
| US-20110155320-A1 | SILANE/UREA COMPOUND AS A HEAT-ACTIVATABLE CURING AGENT FOR EPOXIDE RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2011-06-30 | — | — | US | disclosed |
| EP-2161274-B1 | Silane/urea compound as heat-activated hardener for epoxy resin compounds | SIKA TECHNOLOGY AG (CH) | 2010-05-19 | — | — | EP | disclosed |
| EP-2161274-A1 | Silane/urea compound as heat-activated hardener for epoxy resin compounds | Sika Technology AG (CH) | 2010-03-10 | — | — | EP | disclosed |
| WO-2010023234-A1 | SILANE/UREA COMPOUND AS A HEAT-ACTIVATABLE CURING AGENT FOR EPOXIDE RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2010-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110155320-A1 | SILANE/UREA COMPOUND AS A HEAT-ACTIVATABLE CURING AGENT FOR EPOXIDE RESIN COMPOSITIONS | SEM1, UBA1, UBA3 | MIF 3452/4885TRPA1 2333/4885NAAA 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.